New Method for Imaging Seizures Can Help Guide Epilepsy Surgery
Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery.
Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery.
A new PET imaging agent effectively detects rare medullary thyroid cancer and holds promise for clinical use, with improved stability and tumor uptake achieved through chemical design modifications.
A new AI tool, designed for use with amino acid PET scans, offers an automated and efficient method to detect brain tumors and assess treatment response, matching the quality of experienced physicians but with significantly reduced time requirements, potentially improving brain tumor diagnostics and patient care.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer patients being treated with 177Lu-PSMA radionuclide therapy.
Read MoreResearchers at the University of Wisconsin, Madison, have achieved a breakthrough in the production of scandium radioisotopes, a development with profound implications for the future of medical imaging and cancer treatment.
Read MoreNew research highlights that PSMA PET/CT imaging can potentially diagnose advanced prostate cancer and guide treatment decisions without the need for biopsies in elderly patients, offering accurate staging data and potentially reducing complications associated with biopsies.
Read MoreMontclair, N.J.-based Hackensack Meridian Mountainside Medical Center has unveiled Cerianna, a breast imaging technology from GE HealthCare that helps physician detect and localize breast lesions.
Read MoreA molecular imaging tool developed by researchers at UCLA and UCSF helps improve the accuracy of predicting the risk of cancer recurrence in patients with intermediate to high-risk prostate cancer who undergo surgery.
Read More